- Third Quarter 2014 Net Revenue and Consolidated Adjusted EBITDA Increase 8% and 5% Respectively - - Free Cash Flow Increases 26% - - Establishes New Digital Media Segment -
- Repurchases 0.8 Million Shares in the Third Quarter - SANTA MONICA, Calif.
Record Q3 2014 Revenue of $103 Million; Strong Q3 Adjusted EBITDA* of $8.8 Million Signed Major Strategic Partnership with SES S.A. for Satellite Bandwidth Provisioning Launched Streaming In-flight Music with Beats Music and Southwest Airlines Promoted Michael Zemetra to Chief Financial Officer Strong Balance Sheet with Approximately $210 Million in Cash and Less than $4 Million in Debt
LOS ANGELES, Nov.
Resonant Inc. (NASDAQ: RESN), a late-stage development company creating
innovative filter designs for radio frequency, or RF, front-ends for the
mobile device industry, today announced financial results and provided a
business update for the third quarter ended September 30, 2014.
FREMONT, CA--(Marketwired - November 06, 2014) - Lam Research Corporation (NASDAQ: LRCX) today announced its upcoming investor conference schedule:
About Lam Research:
Lam Research Corp.
Global Net Product Sales for PROCYSBI ® of $23.8 Million for Third Quarter 2014 PROCYSBI Revenue of $52.2 Million Reached Through September 2014 PROCYSBI Revenue Guidance of $65-$70 Million Maintained 2014 Cash Operating Expense Guidance Narrowed to $80-$85 Million
NOVATO, Calif., Nov.
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company
with fully integrated commercial and drug development operations with a
primary focus in hematology and oncology, announced today financial
results for the three-month period ended September 30, 2014.
SOUTH SAN FRANCISCO, CA --
WALNUT CREEK, CA --
Inc. (NYSE:FXCM), a leading online provider of foreign exchange, or
FX, trading and related services, today announced for the quarter ended
September 30, 2014, U.S. GAAP revenues of $116.1 million, compared to
$113.2 million for the quarter ended September 30, 2013, an increase of
3%. U.S. GAAP net income attributable to FXCM Inc. was $2.4 million for
the Third Quarter 2014 or $0.05 per diluted share, compared to U.S. GAAP
net loss of $5.1 million or $0.15 per diluted share for the Third
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.